NeurologyLive Friday 5 — March 13, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending March 13, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: COVID-19: Preventive Measures in Multiple Sclerosis Patients and Others on Immuno-Modulators
Disease-modifying therapies used to treat several immune-mediated disorders in neurology may make patients more susceptible to the novel coronavirus.
2: Psychological Effects of SMA on Children and Adults
Philippa Cheetham, MBChB, MRCS, MD, FRCS, Crystal Proud, MD, and patient Sebastian Mills discuss the psychological impact spinal muscular atrophy can have on children and adults alike.
3: Small Vessel Disease Score Can Improve Dementia Risk Prediction
An analysis of pooled data from 3 longitudinal clinical trials suggests that SVD score, which can be compiled via a rapid visual assessment of clinical MRI scans, may be able to improve the prediction of dementia risk.
4: MRI in the Diagnosis of MS
Expert neurologists outline how the use of MRI has changed the diagnosis of multiple sclerosis and the importance of standardized protocols.
5: Kiran Maski, MD, MPH: Addressing Pediatric Sleep Disorders
The director of the Sleep Clinic at Boston Children’s Hospital discussed the sleep disorders she sees in her practice, and how she and her colleagues best address these pediatric patients.
